ABSTRACTCoenzyme F420plays a key role in the redox metabolisms of various archaea and bacteria, includingMycobacterium tuberculosis. InM. tuberculosis, F420-dependent reactions have been linked to several virulence factors. F420carries multiple glutamate residues in the side chain, forming F420-nspecies (n, number of glutamate residues), and the length of this side chain impacts cellular physiology.M. tuberculosisstrains with F420species carrying shorter side chains exhibit resistance to delamanid and pretomanid, two new tuberculosis (TB) drugs. Thus, the process of polyglutamylation of F420is of great interest. It has been known from genetic analysis that in mycobacteria an F420-0 γ-glutamyl ligase (FbiB) introduces up to seven glutamate residues into F420. However, purified FbiB ofM. tuberculosis(MtbFbiB) is either inefficient or incapable of incorporating more than two glutamates. We found that,in vitro,MtbFbiB synthesized side chains containing up to seven glutamate residues if F420was presented to the enzyme in a two-electron reduced state (F420H2). Our genetic analysis inMycobacterium bovisBCG andMycobacterium smegmatisand an analysis of literature data onM. tuberculosisrevealed that in these mycobacteria the polyglutamylation process requires the assistance of F420-dependent glucose-6-phosphate dehydrogenase (Fgd) which reduces F420to F420H2. We hypothesize that, starting with F420-0H2, the amino-terminal domain of FbiB builds F420-2H2, which is then transferred to the carboxy-terminal domain for further glutamylation; F420-2H2modifies the carboxy-terminal domain structurally to accommodate longer glutamyl chains. This system is analogous to folylpolyglutamate synthase, which introduces more than one glutamate residue into folate only after this vitamin is reduced to tetrahydrofolate.IMPORTANCECoenzyme F420-dependent reactions ofMycobacterium tuberculosis, which causes tuberculosis, potentially contributes to the virulence of this bacterium. The coenzyme carries a glutamic acid-derived tail, the length of which influences the metabolism ofM. tuberculosis. Mutations that eliminate the production of F420with longer tails makeM. tuberculosisresistant to two new tuberculosis drugs. This report describes that the synthesis of longer glutamyl tails of F420requires concerted actions of two enzymes, one of which reduces the coenzyme prior to the action of the other, which catalyzes polyglutamylation. This knowledge will help to develop more effective tuberculosis (TB) drugs. Remarkably, the introduction of multiple glutamate residues into the sidechain of folate (vitamin B9) requires similar concerted actions, where one enzyme reduces the vitamin to tetrahydrofolate and the other catalyzes polyglutamylation; folate is required for DNA and amino acid synthesis. Thus, the reported research has also revealed a key similarity between two important cellular systems.